U.S. Patent Disclosures
Monday, July 1, 2013
Amarin Corp. plc, of Dublin, was issued U.S. Patent notice of allowance No. 13/417,899, "Pharmaceutical Compositions Comprising EPA and a Cardiovascular Agent and Methods of Using the Same." The application covers the use of Vascepa (icosapent ethyl) and statin therapy to reduce triglycerides.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.